TSLP‐targeting therapy: Beyond allergy?
Үндсэн зохиолчид: | Risa Ebina‐Shibuya, Warren J. Leonard |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Wiley
2023-05-01
|
Цуврал: | Clinical and Translational Medicine |
Нөхцлүүд: | |
Онлайн хандалт: | https://doi.org/10.1002/ctm2.1241 |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
-н: Andrew Menzies-Gow, зэрэг
Хэвлэсэн: (2020-10-01) -
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
-н: Andrew Menzies-Gow, зэрэг
Хэвлэсэн: (2020-10-01) -
Role of the TSLP and its Receptor in the Treatment of Asthma
-н: Miguel Estravís, зэрэг
Хэвлэсэн: (2023-04-01) -
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
-н: Corren J, зэрэг
Хэвлэсэн: (2021-01-01) -
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study
-н: Emson C, зэрэг
Хэвлэсэн: (2021-02-01)